Drug watchdog OKs 5 clinical trials of drugs for COVID-19 treatment
SEOUL, March 27 (Yonhap) -- The South Korean drug safety watchdog said Friday it has approved five clinical trials of existing drugs that could be used to treat COVID-19 patients as part of efforts to combat the disease ravaging the world.
Three of the clinical trials involve the Ebola drug Remdesivir and will be carried out by Seoul National University Hospital and National Medical Center, according to the Ministry of Food and Drug Safety.
Asan Medical Center in Seoul and Gangnam Severance Hospital will conduct the remaining two tests using the AIDS treatment Kaletra and the malaria drug hydroxychloroquine.
The ministry said it greenlighted the five clinical trials after fast-tracking 11 applications.
The ministry also said it has given the go-ahead to six applications for the use of a local flu drug being tested for the treatment of patients infected with the novel coronavirus.
South Korean midsized bio firm ImmuneMed has developed the drug HzVSFv13, an injection type of Virus Suppressing Factor (VSF).
The ministry further said it is reviewing 10 other applications for the use of existing drugs to treat COVID-19.
The ministry added it is cooperating with the Korea Centers for Disease Control and Prevention and the science ministry to help develop treatments for the coronavirus.
As of Friday, South Korea had more than 9,300 COVID-19 patients, with the death toll reaching 139.
(END)
-
New Defense Minister Lee takes office, warns of 'stern' response to possible N.K. provocations
-
(LEAD) Yoon taps ex-deputy NSA for spy chief
-
Gov't to significantly increase international flights to meet travel demand
-
(2nd LD) BTS wins three Billboard Music Awards, marking 6th year to win an award
-
(Yonhap Interview) Kiwoom Heroes' ace Eric Jokisch wants to make young sons proud
-
S. Korea to send condolence delegation to UAE over death of president
-
Yoon expresses hope for reopening of Seoul-Tokyo air route to bolster exchanges
-
(LEAD) N. Korea confirms first case of omicron variant of COVID-19: state media
-
Seoul's daily subway ridership hits pandemic-era high on eased restrictions
-
(5th LD) N.K. leader, wearing mask, chairs meeting on omicron outbreak
-
S. Korean volunteer fighter in Ukraine doesn't regret his action despite facing imprisonment at home
-
(LEAD) S. Korea looks into cryptocurrency market following TerraUSD, Luna crash
-
S. Korea's Black Eagles aerobatic team to perform in British air shows in July
-
(LEAD) Crypto investor probed for alleged trespassing at Terraform CEO's home
-
(3rd LD) Pilot killed, 2 others seriously injured in helicopter crash in Geoje